“Synthesis and Characterization of YYGSR-NH2 As a Chemical Starting Poin for Thyroid Theranostic Radiopharmaceutical Development”. JURNAL FARMASIMED (JFM), vol. 9, no. 1, Oct. 2026, pp. 830-41, https://doi.org/10.35451/jfm.v9i1.3856.